Science Explorer Interactive view Map
Company · Lucerne · Switzerland

MSD (Switzerland)

msd.chROR OpenAlex
Research works
82
▲ 60% vs 2013–17
Citations
6.5k
79.5 per fractional work
Top-10% rate
19.9%
record average 16.5%
Open access
65%
world 28%

Not ranked overall: MSD (Switzerland) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Agricultural and Biological Sciences: 0.46× its world share, 1 worksAgricultural and Bio…Biochemistry, Genetics and Molecular Biology: 0.94× its world share, 2 worksBiochemistry, Geneti…Immunology and Microbiology: 2.68× its world share, 1 worksImmunology and Micro…Pharmacology, Toxicology and Pharmaceutics: 0.35× its world share, 0 worksPharmacology, Toxico…Chemistry: 0.28× its world share, 0 worksChemistryComputer Science: 0.15× its world share, 0 worksComputer ScienceEarth and Planetary Sciences: 0.08× its world share, 0 worksEarth and Planetary …Engineering: 0.05× its world share, 0 worksEngineeringEnvironmental Science: 0.12× its world share, 0 worksEnvironmental ScienceMathematics: 3.38× its world share, 1 worksMathematicsHealth Professions: 2.48× its world share, 2 worksHealth ProfessionsMedicine: 2.82× its world share, 16 worksMedicineNursing: 1.13× its world share, 0 worksNursingArts and Humanities: 0.05× its world share, 0 worksArts and HumanitiesBusiness, Management and Accounting: 0.76× its world share, 1 worksBusiness, Management…Decision Sciences: 1.94× its world share, 1 worksDecision SciencesEconomics, Econometrics and Finance: 6.23× its world share, 4 worksEconomics, Econometr…Psychology: 0.10× its world share, 0 worksPsychologySocial Sciences: 0.26× its world share, 1 worksSocial Sciences1×world share
more than its size predictsabout as predictedless

Rings at 0.5×, 1× and 2×. Widest outward: Economics, Econometrics and Finance, 6.2×. Every wedge is a field page.

Which keywords describe research at MSD (Switzerland)?

By fractional works in 2022–2025, weighted toward what it does more of than the world: Epidemiology, Chemotherapy, Clinical Practice Guidelines, Quality of Life, Cost-effectiveness Analysis, Health Utility Measures, Cost of Care and Financial Toxicity.

▲ more of its work than of the world’s◆ about the world’s share▼ less than the world’s

Size is fractional works in 2022–2025 in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 26 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 26 words, with their numbers
  1. Epidemiology6▲ 4.7×29 topics
  2. Quality of Life2▲ 5.3×6 topics
  3. Chemotherapy2▲ 10×11 topics
  4. Clinical Practice Guidelines2▲ 13×10 topics
  5. Cost-effectiveness Analysis2▲ 74×1 topic
  6. Health Utility Measures2▲ 74×1 topic
  7. Public Health2▲ 3.7×6 topics
  8. Cost of Care2▲ 170×1 topic
  9. Financial Toxicity2▲ 170×1 topic
  10. Primary Care2▲ 13×5 topics
  11. Biomarkers1▲ 6.9×3 topics
  12. Pathogenesis1▲ 9.4×8 topics
  13. Clinical Trials1▲ 6.2×6 topics
  14. Tumor Microenvironment1▲ 9.6×3 topics
  15. Treatment1▲ 3.2×7 topics
  16. Treatment Guidelines1▲ 18×2 topics
  17. Vaccine1▲ 9.5×7 topics
  18. Antimicrobial Resistance1▲ 19×3 topics
  19. Healthcare Quality Indicators1▲ 62×2 topics
  20. Molecular Characterization1▲ 20×4 topics
  21. Diagnosis1▲ 3.7×6 topics
  22. Healthcare Policy1▲ 35×1 topic
  23. Immune Checkpoint Blockade1▲ 31×1 topic
  24. Inequalities1▲ 95×1 topic
  25. PD-1 and PD-L11▲ 31×1 topic
  26. Risk Factors1▲ 3.0×5 topics

Which research topics does MSD (Switzerland) publish most on?

By volume in 2022–2025: Health Systems, Economic Evaluations, Quality of Life, Economic and Financial Impacts of Cancer, Healthcare Systems and Practices and Cancer Immunotherapy and Biomarkers.

Health Systems, Economic Evaluations, Quality of Life: 2 fractional worksEconomic and Financial Impacts of Cancer: 2 fractional worksHealthcare Systems and P…1Healthcare Systems and Practices: 1 fractional worksCancer Immunotherapy and…1Cancer Immunotherapy and Biomarkers: 1 fractional worksStatistical Methods in Clinical Trials: 1 fractional worksPneumonia and Respiratory Infections: 1 fractional worksPulmonary Hypertension R…1Pulmonary Hypertension Research and Treatments: 1 fractional worksRespiratory viral infections research: 1 fractional worksGlobal Cancer Incidence and Screening: 0 fractional worksGastric Cancer Management and Outcomes: 0 fractional works
Economics and EconometricsGeneral Health ProfessionsOncologyStatistics and Probability2 others

Area is fractional works; colour is the subfield each topic belongs to.

  1. 1 Health Systems, Economic Evaluations, Quality of Life Economics and Econometrics 2 works
  2. 2 Economic and Financial Impacts of Cancer Economics and Econometrics 2 works
  3. 3 Healthcare Systems and Practices General Health Professions 1 works
  4. 4 Cancer Immunotherapy and Biomarkers Oncology 1 works
  5. 5 Statistical Methods in Clinical Trials Statistics and Probability 1 works
  6. 6 Pneumonia and Respiratory Infections Epidemiology 1 works
  7. 7 Pulmonary Hypertension Research and Treatments Pulmonary and Respiratory Medicine 1 works
  8. 8 Respiratory viral infections research Epidemiology 1 works
  9. 9 Global Cancer Incidence and Screening Oncology 0 works
  10. 10 Gastric Cancer Management and Outcomes Pulmonary and Respiratory Medicine 0 works

How open and international is its research?

Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available65.3%not open34.7%

World: 28% of research is openly available.

with international co-authors72.4%domestic only27.6%

World: 19% is written across borders.

How has MSD (Switzerland)'s research output changed?

Output in 2018–2022 was 60% higher than in 2013–2017.

1990200020102020
grewheldshrank

The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.

Other research institutions in Lucerne

All research institutions in Lucerne

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.